Figure 1.
![Figure 1. Cytotoxicity assay. Bone marrow mononuclear cells from 8 patients treated with CEP-701 were incubated in vitro (in cell culture medium) with increasing concentrations of CEP-701. Each drug concentration point was performed in triplicate. At 72 hours, metabolic activity was determined using the MTT assay. Results are plotted for each sample as percentage (optical density [OD]) of untreated control. Error bars represent SE.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/103/10/10.1182_blood-2003-11-3775/6/zh80090460740001.jpeg?Expires=1750052300&Signature=yB6oUtVYiydBVfXlph40FVM6pM8LoFlDiv2mu2u3bLs610O~--qybdpFVTCf6Y5iLx~BEUNH~wDmYcltVAJwJSdgpPeI14cjc3AbPGzsQlXw5rB1BjMvNkyhV0Mx7Rcb3btfXJngqBKIGwuw9HblGnrKSJmj2p3ywfUxBy3h8KMnV7Oy2WX68904BE1fQaljWgRTcTeRlBk1zIWPX2IJsWS7VUBOhgbkJm6PcHFmA6aQrqrGlNTfvjYRCKTPrWrlXSc0IHirBl-4AGF6bDPD9TZzyql1WGKbvCMRVyy-4jwfp5BZmcOHQz9kN2NqhSze0gJdrVbVnuKE7FijmjwgyQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Cytotoxicity assay. Bone marrow mononuclear cells from 8 patients treated with CEP-701 were incubated in vitro (in cell culture medium) with increasing concentrations of CEP-701. Each drug concentration point was performed in triplicate. At 72 hours, metabolic activity was determined using the MTT assay. Results are plotted for each sample as percentage (optical density [OD]) of untreated control. Error bars represent SE.
